Hoyeon Jeong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hoyeon Jeong has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Dae Ryong Kang
Department of Precision Medicine & Biostatistics, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
9 shared publications - Yoon-La Choi
Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
3 shared publications - Hyeon Chang Kim
Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea
2 shared publications - Jang Young Kim
Division of Cardiology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University, Wonju, Korea
2 shared publications - Jeong-Hun Shin
Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea
2 shared publications - Ji Hye Huh
Department of Internal Medicine, Hallym University College of Medicine , Hallymdaehak-Gil Chuncheon-si, Gangwon-do, Chuncheon 24252
2 shared publications
Latest Publications
- Open Access
- 7 January 2026
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 27 (1)
SHEST: single-cell-level artificial intelligence from haematoxylin and eosin morphology for cell-type prediction and spatial transcriptomics reconstruction
A comprehensive understanding of cancer progression requires integrating tissue morphology with spatial molecular profiles. We present SHEST, a multi-task profiling framework that leverages haematoxylin and eosin morphology to predict cellular composition and reconstruct spatial gene expression at single-cell resolution. SHEST employs a quadruple-tile input capturing nuclear and contextual information, combined with a neighbourhood-informed clustering algorithm to filter ambiguous cellular signals. It comprises a shared morphological encoder with two task-specific heads: a classifier for cell-type prediction and a reconstructor for gene expression. Multi-task optimization uses cross-entropy and zero-inflated negative binomial losses, specifically addressing the sparsity of spatial transcriptomic data. Evaluation on human lung adenocarcinoma datasets demonstrated high accuracy for the principal reciprocal constituents of the tumour–immune axis ($F_{1}$: 0.97 for tumour cells and 0.91 for lymphocytes). External validation confirmed its generalizability, revealing alveolar cells and their early neoplastic transitions. Reconstructed gene expression reproduced spatially resolved, cell-type-specific marker patterns—EPCAM in tumour cells, LTBP2 in fibroblasts, and CD3E in lymphocytes—recovering biologically coherent transcriptional architecture. SHEST also preserved distance-dependent spatial relationships and gene-level autocorrelation, reflecting the multicellular niche structure of the tumour microenvironment. By unifying cell-type identification, gene expression reconstruction, and spatial mapping within a single interpretable framework, SHEST provides a synergistic and cost-efficient bridge between histopathology and spatial transcriptomics. This approach facilitates comprehensive tissue characterization and forms a foundation for precision oncology through spatially informed, cell-level insights into tumour–immune ecosystems.
- 7 January 2026
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 27 (1)
Open AccessSHEST: single-cell-level artificial intelligence from haematoxylin and eosin morphology for cell-type prediction and spatial transcriptomics reconstruction
A comprehensive understanding of cancer progression requires integrating tissue morphology with spatial molecular profiles. We present SHEST, a multi-task profiling framework that leverages haematoxylin and eosin morphology to predict cellular composition and reconstruct spatial gene expression at single-cell resolution. SHEST employs a quadruple-tile input capturing nuclear and contextual information, combined with a neighbourhood-informed clustering algorithm to filter ambiguous cellular signals. It comprises a shared morphological encoder with two task-specific heads: a classifier for cell-type prediction and a reconstructor for gene expression. Multi-task optimization uses cross-entropy and zero-inflated negative binomial losses, specifically addressing the sparsity of spatial transcriptomic data. Evaluation on human lung adenocarcinoma datasets demonstrated high accuracy for the principal reciprocal constituents of the tumour–immune axis ($F_{1}$: 0.97 for tumour cells and 0.91 for lymphocytes). External validation confirmed its generalizability, revealing alveolar cells and their early neoplastic transitions. Reconstructed gene expression reproduced spatially resolved, cell-type-specific marker patterns—EPCAM in tumour cells, LTBP2 in fibroblasts, and CD3E in lymphocytes—recovering biologically coherent transcriptional architecture. SHEST also preserved distance-dependent spatial relationships and gene-level autocorrelation, reflecting the multicellular niche structure of the tumour microenvironment. By unifying cell-type identification, gene expression reconstruction, and spatial mapping within a single interpretable framework, SHEST provides a synergistic and cost-efficient bridge between histopathology and spatial transcriptomics. This approach facilitates comprehensive tissue characterization and forms a foundation for precision oncology through spatially informed, cell-level insights into tumour–immune ecosystems.
- Open Access
SHEST: Single-cell-level artificial intelligence from haematoxylin and eosin morphology for cell type prediction and spatial transcriptomics reconstruction
A comprehensive understanding of cancer progression requires integrating tissue morphol-ogy with spatial molecular profiles. We present SHEST, a multi-task profiling framework that leverages haematoxylin and eosin morphology to predict cellular composition and re-construct spatial gene expression at single-cell resolution. SHEST employs a quadruple-tile input capturing nuclear and contextual information, combined with a neighbourhood-informed clustering algorithm to filter ambiguous cellular signals. It comprises a shared morphological encoder with two task-specific heads: a classifier for cell type prediction and a reconstruc-tor for gene expression. Multi-task optimisation uses cross-entropy and zero-inflated negative binomial losses, specifically addressing the sparsity of spatial transcriptomic data. Evalua-tion on human lung adenocarcinoma datasets demonstrated high accuracy for the principal reciprocal constituents of the tumour–immune axis ( F 1 : 0.97 for tumour cells and 0.91 for lym-phocytes). External validation confirmed its generalisability, revealing alveolar cells and their early neoplastic transitions. Reconstructed gene expression reproduced spatially resolved, cell-type-specific marker patterns— EPCAM in tumour cells, LTBP2 in fibroblasts, and CD3E in lymphocytes—recovering biologically coherent transcriptional architecture. SHEST also pre-served distance-dependent spatial relationships and gene-level autocorrelation, reflecting the multicellular niche structure of the tumour microenvironment. By unifying cell type iden-tification, gene expression reconstruction, and spatial mapping within a single interpretable framework, SHEST provides a synergistic and cost-efficient bridge between histopathology and spatial transcriptomics. This approach facilitates comprehensive tissue characterisation and forms a foundation for precision oncology through spatially informed, cell-level insights into tumour–immune ecosystems.
Open AccessSHEST: Single-cell-level artificial intelligence from haematoxylin and eosin morphology for cell type prediction and spatial transcriptomics reconstruction
A comprehensive understanding of cancer progression requires integrating tissue morphol-ogy with spatial molecular profiles. We present SHEST, a multi-task profiling framework that leverages haematoxylin and eosin morphology to predict cellular composition and re-construct spatial gene expression at single-cell resolution. SHEST employs a quadruple-tile input capturing nuclear and contextual information, combined with a neighbourhood-informed clustering algorithm to filter ambiguous cellular signals. It comprises a shared morphological encoder with two task-specific heads: a classifier for cell type prediction and a reconstruc-tor for gene expression. Multi-task optimisation uses cross-entropy and zero-inflated negative binomial losses, specifically addressing the sparsity of spatial transcriptomic data. Evalua-tion on human lung adenocarcinoma datasets demonstrated high accuracy for the principal reciprocal constituents of the tumour–immune axis ( F 1 : 0.97 for tumour cells and 0.91 for lym-phocytes). External validation confirmed its generalisability, revealing alveolar cells and their early neoplastic transitions. Reconstructed gene expression reproduced spatially resolved, cell-type-specific marker patterns— EPCAM in tumour cells, LTBP2 in fibroblasts, and CD3E in lymphocytes—recovering biologically coherent transcriptional architecture. SHEST also pre-served distance-dependent spatial relationships and gene-level autocorrelation, reflecting the multicellular niche structure of the tumour microenvironment. By unifying cell type iden-tification, gene expression reconstruction, and spatial mapping within a single interpretable framework, SHEST provides a synergistic and cost-efficient bridge between histopathology and spatial transcriptomics. This approach facilitates comprehensive tissue characterisation and forms a foundation for precision oncology through spatially informed, cell-level insights into tumour–immune ecosystems.
- Open Access
GraphTME: a framework for predicting response to immune checkpoint inhibitors by interpreting cell-cell interactions in the tumour microenvironment using spatial transcriptomics of tumour tissue
Immune checkpoint inhibitors (ICIs) have been used to treat cancer by reactivating T-cell responses against tumours, yet clinical efficacy remains limited due to low response rates and the lack of robust predictive biomarkers. The tumour microenvironment critically shapes ICI responsiveness by modulating antitumour immunity, necessitating a deeper understanding of spatially organised cell–cell interactions. Imaging-based spatial transcriptomics (ST) enables such analysis at single-cell resolution. We present GraphTME, a spatially informed and biologically interpretable framework that models pathway-specific directional cell–cell interactions to predict anti-PD-1 response. Ligand–receptor interactions are organised by signalling pathways and represented as a multi-relational directed graph, with edge weights inversely scaled by spatial distance. Using CD8 + T cells from single-cell RNA-seq data of ICI-treated NSCLC patients, we trained a relational graph convolutional network to infer immune responsiveness. GraphTME achieved an F 1 score exceeding 0.83 in predicting ICI response and was validated using MERFISH data from an NSCLC patient with a partial response. Predicted responder CD8 + T cells exhibited higher abundance and stronger directional signalling to tumour cells. They also expressed genes associated with antitumour activity, while non-responders showed expression patterns linked to poor prognosis. GraphTME is the first framework to quantitatively model single-cell-level interactions within the spatial architecture of tumour tissues and predict ICI responses from these interactions. It offers a spatially resolved, biologically grounded biomarker for immunotherapy and a tool for dissecting immune dynamics in situ .
Open AccessGraphTME: a framework for predicting response to immune checkpoint inhibitors by interpreting cell-cell interactions in the tumour microenvironment using spatial transcriptomics of tumour tissue
Immune checkpoint inhibitors (ICIs) have been used to treat cancer by reactivating T-cell responses against tumours, yet clinical efficacy remains limited due to low response rates and the lack of robust predictive biomarkers. The tumour microenvironment critically shapes ICI responsiveness by modulating antitumour immunity, necessitating a deeper understanding of spatially organised cell–cell interactions. Imaging-based spatial transcriptomics (ST) enables such analysis at single-cell resolution. We present GraphTME, a spatially informed and biologically interpretable framework that models pathway-specific directional cell–cell interactions to predict anti-PD-1 response. Ligand–receptor interactions are organised by signalling pathways and represented as a multi-relational directed graph, with edge weights inversely scaled by spatial distance. Using CD8 + T cells from single-cell RNA-seq data of ICI-treated NSCLC patients, we trained a relational graph convolutional network to infer immune responsiveness. GraphTME achieved an F 1 score exceeding 0.83 in predicting ICI response and was validated using MERFISH data from an NSCLC patient with a partial response. Predicted responder CD8 + T cells exhibited higher abundance and stronger directional signalling to tumour cells. They also expressed genes associated with antitumour activity, while non-responders showed expression patterns linked to poor prognosis. GraphTME is the first framework to quantitatively model single-cell-level interactions within the spatial architecture of tumour tissues and predict ICI responses from these interactions. It offers a spatially resolved, biologically grounded biomarker for immunotherapy and a tool for dissecting immune dynamics in situ .
- Open Access
Development and Validation of a Real-Time Service Model for Noise Removal and Arrhythmia Classification Using Electrocardiogram Signals
Arrhythmias range from mild nuisances to potentially fatal conditions, detectable through electrocardiograms (ECGs). With advancements in wearable technology, ECGs can now be monitored on-the-go, although these devices often capture noisy data, complicating accurate arrhythmia detection. This study aims to create a new deep learning model that utilizes generative adversarial networks (GANs) for effective noise removal and ResNet for precise arrhythmia classification from wearable ECG data. We developed a deep learning model that cleans ECG measurements from wearable devices and detects arrhythmias using refined data. We pretrained our model using the MIT-BIH Arrhythmia and Noise databases. Least squares GANs were used for noise reduction, maintaining the integrity of the original ECG signal, while a residual network classified the type of arrhythmia. After initial training, we applied transfer learning with actual ECG data. Our noise removal model significantly enhanced data clarity, achieving over 30 dB in a signal-to-noise ratio. The arrhythmia detection model was highly accurate, with an F1-score of 99.10% for noise-free data. The developed model is capable of real-time, accurate arrhythmia detection using wearable ECG devices, allowing for immediate patient notification and facilitating timely medical response.
Open AccessDevelopment and Validation of a Real-Time Service Model for Noise Removal and Arrhythmia Classification Using Electrocardiogram Signals
Arrhythmias range from mild nuisances to potentially fatal conditions, detectable through electrocardiograms (ECGs). With advancements in wearable technology, ECGs can now be monitored on-the-go, although these devices often capture noisy data, complicating accurate arrhythmia detection. This study aims to create a new deep learning model that utilizes generative adversarial networks (GANs) for effective noise removal and ResNet for precise arrhythmia classification from wearable ECG data. We developed a deep learning model that cleans ECG measurements from wearable devices and detects arrhythmias using refined data. We pretrained our model using the MIT-BIH Arrhythmia and Noise databases. Least squares GANs were used for noise reduction, maintaining the integrity of the original ECG signal, while a residual network classified the type of arrhythmia. After initial training, we applied transfer learning with actual ECG data. Our noise removal model significantly enhanced data clarity, achieving over 30 dB in a signal-to-noise ratio. The arrhythmia detection model was highly accurate, with an F1-score of 99.10% for noise-free data. The developed model is capable of real-time, accurate arrhythmia detection using wearable ECG devices, allowing for immediate patient notification and facilitating timely medical response.
- Open Access
- 27 March 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (3) , e0291223
GraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure
Neoantigens are tumor-derived peptides and are biomarkers that can predict prognosis related to immune checkpoint inhibition by estimating their binding to major histocompatibility complex (MHC) proteins. Although deep neural networks have been primarily used for these prediction models, it is difficult to interpret the models reported thus far as accurately representing the interactions between biomolecules. In this study, we propose the GraphMHC model, which utilizes a graph neural network model applied to molecular structure to simulate the binding between MHC proteins and peptide sequences. Amino acid sequences sourced from the immune epitope database (IEDB) undergo conversion into molecular structures. Subsequently, atomic intrinsic informations and inter-atomic connections are extracted and structured as a graph representation. Stacked graph attention and convolution layers comprise the GraphMHC network which classifies bindings. The prediction results from the test set using the GraphMHC model showed a high performance with an area under the receiver operating characteristic curve of 92.2% (91.9-92.5%), surpassing a baseline model. Moreover, by applying the GraphMHC model to melanoma patient data from The Cancer Genome Atlas project, we found a borderline difference (0.061) in overall survival and a significant difference in stromal score between the high and low neoantigen load groups. This distinction was not present in the baseline model. This study presents the first feature-intrinsic method based on biochemical molecular structure for modeling the binding between MHC protein sequences and neoantigen candidate peptide sequences. This model can provide highly accurate responsibility information that can predict the prognosis of immune checkpoint inhibitors to cancer patients who want to apply it.
- 27 March 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (3) , e0291223
Open AccessGraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure
Neoantigens are tumor-derived peptides and are biomarkers that can predict prognosis related to immune checkpoint inhibition by estimating their binding to major histocompatibility complex (MHC) proteins. Although deep neural networks have been primarily used for these prediction models, it is difficult to interpret the models reported thus far as accurately representing the interactions between biomolecules. In this study, we propose the GraphMHC model, which utilizes a graph neural network model applied to molecular structure to simulate the binding between MHC proteins and peptide sequences. Amino acid sequences sourced from the immune epitope database (IEDB) undergo conversion into molecular structures. Subsequently, atomic intrinsic informations and inter-atomic connections are extracted and structured as a graph representation. Stacked graph attention and convolution layers comprise the GraphMHC network which classifies bindings. The prediction results from the test set using the GraphMHC model showed a high performance with an area under the receiver operating characteristic curve of 92.2% (91.9-92.5%), surpassing a baseline model. Moreover, by applying the GraphMHC model to melanoma patient data from The Cancer Genome Atlas project, we found a borderline difference (0.061) in overall survival and a significant difference in stromal score between the high and low neoantigen load groups. This distinction was not present in the baseline model. This study presents the first feature-intrinsic method based on biochemical molecular structure for modeling the binding between MHC protein sequences and neoantigen candidate peptide sequences. This model can provide highly accurate responsibility information that can predict the prognosis of immune checkpoint inhibitors to cancer patients who want to apply it.
- Open Access
GraphMHC: neoantigen prediction model applying the graph neural network to molecular structure
Neoantigens are biomarkers that can predict the prognosis associated with immune checkpoint inhibition by estimating the binding potential of candidate peptides to somatic mutation and major histocompatibility complex (MHC) proteins. Although deep neural networks have been primarily used for these prediction models, it is difficult to consider the models reported thus far as accurately representing the interactions between biomolecules. In this study, we propose the GraphMHC model, which utilizes a graph neural network model through molecular structure to simulate the binding between MHC proteins and peptide sequences. Amino acid sequences sourced from the immune epitope database (IEDB) undergo conversion into molecular structures. Subsequently, atomic intrinsic informations and inter-atomic connections are extracted and structured as a graph representation. Bindings are classified by feeding them into the GraphMHC network, comprising stacked graph attention and convolution layers. The prediction results from the test set using the GraphMHC model showed a high performance with an area under the receiver operating characteristic curve of 92.2% (91.9-92.5%), surpassing the baseline model. Moreover, by applying the GraphMHC model to melanoma patient data from the Cancer Genome Atlas project, we found a borderline difference in overall survival and a significant difference in stromal score between the high and low neoantigen load groups. This distinction was not present in the baseline model. This study presents the first feature-intrinsic method based on biochemical molecular structure for modeling the binding between MHC protein sequences and neoantigen candidate peptide sequences. The model can provide highly accurate suitability information for cancer patients who want to apply immune checkpoint inhibitors. Author summary:
Open AccessGraphMHC: neoantigen prediction model applying the graph neural network to molecular structure
Neoantigens are biomarkers that can predict the prognosis associated with immune checkpoint inhibition by estimating the binding potential of candidate peptides to somatic mutation and major histocompatibility complex (MHC) proteins. Although deep neural networks have been primarily used for these prediction models, it is difficult to consider the models reported thus far as accurately representing the interactions between biomolecules. In this study, we propose the GraphMHC model, which utilizes a graph neural network model through molecular structure to simulate the binding between MHC proteins and peptide sequences. Amino acid sequences sourced from the immune epitope database (IEDB) undergo conversion into molecular structures. Subsequently, atomic intrinsic informations and inter-atomic connections are extracted and structured as a graph representation. Bindings are classified by feeding them into the GraphMHC network, comprising stacked graph attention and convolution layers. The prediction results from the test set using the GraphMHC model showed a high performance with an area under the receiver operating characteristic curve of 92.2% (91.9-92.5%), surpassing the baseline model. Moreover, by applying the GraphMHC model to melanoma patient data from the Cancer Genome Atlas project, we found a borderline difference in overall survival and a significant difference in stromal score between the high and low neoantigen load groups. This distinction was not present in the baseline model. This study presents the first feature-intrinsic method based on biochemical molecular structure for modeling the binding between MHC protein sequences and neoantigen candidate peptide sequences. The model can provide highly accurate suitability information for cancer patients who want to apply immune checkpoint inhibitors. Author summary:
- Open Access
- 14 February 2023
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 45, e2023020
Evaluation of an air quality warning system for vulnerable and susceptible individuals in Korea: an interrupted time series analysis
OBJECTIVES: This study was conducted to elucidate the effects of an air quality warning system (AQWS) implemented in January 2015 in Korea by analyzing changes in the incidence and exacerbation rates of environmental diseases.METHODS: Data from patients with environmental diseases were extracted from the National Health Insurance Service-National Sample Cohort database from 2010 to 2019, and data on environmental risk factors were acquired from the AirKorea database. Patient and meteorological data were linked based on residential area. An interrupted time series analysis with Poisson segmented regression was used to compare the rates before and after AQWS introduction. Adjustment variables included seasonality, air pollutants (carbon monoxide, nitrogen dioxide, sulfur dioxide, particulate matter less than 10 μm in diameter, and ozone), temperature, and humidity.RESULTS: After AQWS implementation, the incidence of asthma gradually decreased by 20.5%. Cardiovascular disease and stroke incidence also significantly decreased (by 34.3 and 43.0%, respectively). However, no immediate or gradual decrease was identified in the exacerbation rate of any environmental disease after AQWS implementation. Sensitivity analyses were performed according to age, disability, and health insurance coverage type. Overall, the AQWS effectively mitigated the occurrence of most environmental diseases in Korea. However, the relationships between alarm system implementation and reduced incidence differed among diseases based on the characteristics of vulnerable and sensitive individuals.CONCLUSIONS: Our results suggest that by tailoring the AQWS to demographic and sociological characteristics and providing enhanced education about the warning system, interventions can become an efficient policy tool to decrease air pollution-related health risks.
- 14 February 2023
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 45, e2023020
Open AccessEvaluation of an air quality warning system for vulnerable and susceptible individuals in Korea: an interrupted time series analysis
OBJECTIVES: This study was conducted to elucidate the effects of an air quality warning system (AQWS) implemented in January 2015 in Korea by analyzing changes in the incidence and exacerbation rates of environmental diseases.METHODS: Data from patients with environmental diseases were extracted from the National Health Insurance Service-National Sample Cohort database from 2010 to 2019, and data on environmental risk factors were acquired from the AirKorea database. Patient and meteorological data were linked based on residential area. An interrupted time series analysis with Poisson segmented regression was used to compare the rates before and after AQWS introduction. Adjustment variables included seasonality, air pollutants (carbon monoxide, nitrogen dioxide, sulfur dioxide, particulate matter less than 10 μm in diameter, and ozone), temperature, and humidity.RESULTS: After AQWS implementation, the incidence of asthma gradually decreased by 20.5%. Cardiovascular disease and stroke incidence also significantly decreased (by 34.3 and 43.0%, respectively). However, no immediate or gradual decrease was identified in the exacerbation rate of any environmental disease after AQWS implementation. Sensitivity analyses were performed according to age, disability, and health insurance coverage type. Overall, the AQWS effectively mitigated the occurrence of most environmental diseases in Korea. However, the relationships between alarm system implementation and reduced incidence differed among diseases based on the characteristics of vulnerable and sensitive individuals.CONCLUSIONS: Our results suggest that by tailoring the AQWS to demographic and sociological characteristics and providing enhanced education about the warning system, interventions can become an efficient policy tool to decrease air pollution-related health risks.
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (19) , e145
Comparison of Newly Proposed LDL-Cholesterol Estimation Equations
Jeong YW, et al. J Korean Med Sci. 2023 Apr;38(19):e145. https://doi.org/10.3346/jkms.2023.38.e145
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (19) , e145
Open AccessComparison of Newly Proposed LDL-Cholesterol Estimation Equations
Jeong YW, et al. J Korean Med Sci. 2023 Apr;38(19):e145. https://doi.org/10.3346/jkms.2023.38.e145
- Open Access
- 4 November 2022
- Published by SAGE Publications in Digital Health
- Vol. 8
Applications of deep learning methods in digital biomarker research using noninvasive sensing data
Introduction: Noninvasive digital biomarkers are critical elements in digital healthcare in terms of not only the ease of measurement but also their use of raw data. In recent years, deep learning methods have been put to use to analyze these diverse heterogeneous data; these methods include representation learning for feature extraction and supervised learning for the prediction of these biomarkers. Methods: We introduce clinical cases of digital biomarkers and various deep-learning methods applied according to each data type. In addition, deep learning methods for the integrated analysis of multidimensional heterogeneous data are introduced, and the utility of these data as an integrated digital biomarker is presented. The current status of digital biomarker research is examined by surveying research cases applied to various types of data as well as modeling methods. Results: We present a future research direction for using data from heterogeneous sources together by introducing deep learning methods for dimensionality reduction and mode integration from multimodal digital biomarker studies covering related domains. The integration of multimodality has led to advances in research through the improvement of performance and complementarity between modes. Discussion: The integrative digital biomarker will be more useful for research on diseases that require data from multiple sources to be treated together. Since delicate signals from patients are not missed and the interaction effects between signals are also considered, it will be helpful for immediate detection and more accurate prediction of symptoms.
- 4 November 2022
- Published by SAGE Publications in Digital Health
- Vol. 8
Open AccessApplications of deep learning methods in digital biomarker research using noninvasive sensing data
Introduction: Noninvasive digital biomarkers are critical elements in digital healthcare in terms of not only the ease of measurement but also their use of raw data. In recent years, deep learning methods have been put to use to analyze these diverse heterogeneous data; these methods include representation learning for feature extraction and supervised learning for the prediction of these biomarkers. Methods: We introduce clinical cases of digital biomarkers and various deep-learning methods applied according to each data type. In addition, deep learning methods for the integrated analysis of multidimensional heterogeneous data are introduced, and the utility of these data as an integrated digital biomarker is presented. The current status of digital biomarker research is examined by surveying research cases applied to various types of data as well as modeling methods. Results: We present a future research direction for using data from heterogeneous sources together by introducing deep learning methods for dimensionality reduction and mode integration from multimodal digital biomarker studies covering related domains. The integration of multimodality has led to advances in research through the improvement of performance and complementarity between modes. Discussion: The integrative digital biomarker will be more useful for research on diseases that require data from multiple sources to be treated together. Since delicate signals from patients are not missed and the interaction effects between signals are also considered, it will be helpful for immediate detection and more accurate prediction of symptoms.
- 20 October 2022
- Published by The Korean Society for Noise and Vibration Engineering in Transactions of the Korean Society for Noise and Vibration Engineering
- Vol. 32 (5) , 495-501
Study on Vibration Characteristics of a Ship's Fixed CO2 Fire-extinguishing System for USCG Type Approval
In accordance with the USCG type approval procedure, a fixed CO₂ fire-extinguishing system is mounted on a ship after obtaining type approval. For it to pass the vibration test for type approval, an appropriate vibration resistance design is required. In this study, we analyzed the severity of the vibration test standard UL2127 and developed a modularized test method for USCG type approval. Based on the proposed test method, the vibration response characteristics of each module were evaluated with three-axis vibration test machines. In the case of the cylinder module, damage was caused by excessive vibrations due to resonance, which can be mitigated by changing the rigidity of the boundary structure and shifting the natural frequency out of the frequency range of interest.
- 20 October 2022
- Published by The Korean Society for Noise and Vibration Engineering in Transactions of the Korean Society for Noise and Vibration Engineering
- Vol. 32 (5) , 495-501
Study on Vibration Characteristics of a Ship's Fixed CO2 Fire-extinguishing System for USCG Type Approval
In accordance with the USCG type approval procedure, a fixed CO₂ fire-extinguishing system is mounted on a ship after obtaining type approval. For it to pass the vibration test for type approval, an appropriate vibration resistance design is required. In this study, we analyzed the severity of the vibration test standard UL2127 and developed a modularized test method for USCG type approval. Based on the proposed test method, the vibration response characteristics of each module were evaluated with three-axis vibration test machines. In the case of the cylinder module, damage was caused by excessive vibrations due to resonance, which can be mitigated by changing the rigidity of the boundary structure and shifting the natural frequency out of the frequency range of interest.